Literature DB >> 9010968

Thyroid gland disorders in primary Sjögren's syndrome.

L Punzi1, P A Ostuni, C Betterle, P De Sandre, C Botsios, P F Gambari.   

Abstract

OBJECTIVES: To evaluate the frequency of thyroid disorders in primary Sjögen's syndrome. PATIENTS AND METHODS: 121 consecutive patients meeting Vitali's criteria for primary Sjögren's syndrome and 74 with rheumatoid arthritis underwent thyroid hormone assays, tests for antimicrosomal and antithyroglobulin antibodies, tests for antinuclear antibodies and antibodies to extractable nuclear antigens. Antimicrosomal and antithyroglobulin antibodies were also assayed in 404 controls.
RESULTS: frequencies were calculated separately in males and females, and data in females were subjected to statistical analysis. As compared with controls, Sjögren's syndrome patients were more likely to have antimicrosomal antibodies (9% versus 17.6%, P < 0.05) and both Sjögren's syndrome and rheumatoid arthritis patients were more likely to have antithyroglobulin antibodies (1% versus 13.4% and 10.9%, respectively, P < 0.0001). Hypothyroidism was more common among Sjögren's syndrome patients (13.4%) than rheumatoid arthritis patients (3.1%) (P < 0.05). Sjögren's syndrome patients with thyroid disorders were less likely to have antinuclear antibodies, rheumatoid factors or a Chisholm's stage 3 or 4 lip biopsy.
CONCLUSIONS: our data confirm that thyroid disorders are more common in primary Sjögren's syndrome than in rheumatoid arthritis and controls. Production of autoantibodies and severe histologic lesions were less common in Sjögren's syndrome patients with than without thyroid disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010968

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  8 in total

1.  Association of systemic and thyroid autoimmune diseases.

Authors:  Edit Biró; Zoltán Szekanecz; László Czirják; Katalin Dankó; Emese Kiss; Nóra Anna Szabó; Gabriella Szucs; Margit Zeher; Edit Bodolay; Gyula Szegedi; Gyula Bakó
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

2.  The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Cinzia Scambi; Sara Pieropan; Giovanni Barausse; Silvano Adami
Journal:  Rheumatol Int       Date:  2012-11-05       Impact factor: 2.631

3.  Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.

Authors:  R Tunc; M S Gonen; O Acbay; V Hamuryudan; H Yazici
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  Thyroid disease in Sjögren's syndrome.

Authors:  Luis J Jara; Carmen Navarro; María del Pilar Brito-Zerón; Mario García-Carrasco; Ricardo O Escárcega; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2007-06-09       Impact factor: 2.980

5.  Increased risk of primary Sjögren's syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan.

Authors:  Ming-Chi Lu; Wen-Yao Yin; Tzung-Yi Tsai; Malcolm Koo; Ning-Sheng Lai
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

Review 6.  The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders.

Authors:  Chiara Baldini; Francesco Ferro; Marta Mosca; Poupak Fallahi; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-03       Impact factor: 5.555

7.  Increased risk of thyroid disease in patients with Sjogren's syndrome: a systematic review and meta-analysis.

Authors:  Xin Sun; Li Lu; Yanbin Li; Rong Yang; Ling Shan; Yang Wang
Journal:  PeerJ       Date:  2019-03-19       Impact factor: 2.984

Review 8.  Increased Threat of Thyroid Diseases in Patients With Sjogren's Syndrome: A Systematic Review.

Authors:  Harkirat Kaur; Mohammad Alazzeh; Abhay Thandavaram; Aneeta Channar; Ansh Purohit; Bijay Shrestha; Deepkumar Patel; Hriday Shah; Kerollos Hanna; Lubna Mohammed
Journal:  Cureus       Date:  2022-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.